Dr. Rana Ramzi McKay, MD

  • San Diego, CA
  • Hematologist and oncologist
NPI1306013610PAC ID1557538626
Medicare services, 2024
637
Medicare patients, 2024
225
Part D claims, 2024
359
Publications
263
Clinical trials
10
Practice address
200 W Arbor Dr, San Diego, CA 92103
Practice phone
Call (619) 543-6222
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

UCSD Hillcrest Medical Center

San Diego, California

See all 3 affiliations

Find Dr. McKay's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Rana Ramzi McKay is a hematologist and oncologist in San Diego, California

Dr. McKay practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. McKay's NPI, 1306013610, was assigned on May 15, 2008. Dr. McKay graduated from University Of Florida College Of Medicine in 2008. Dr. McKay holds California license A145444.

NPI and contact details
Medicare PAC ID
1557538626
NPI enumeration date
May 15, 2008
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(619) 543-6222
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
44
Medical school graduation
2008

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Rana Ramzi McKay practices at UCSD Hillcrest Medical Center in San Diego, California

Dr. McKay's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

  • UCSD Hillcrest Medical Center
    200 W Arbor Dr, San Diego, CA 92103 · San Diego CountyPhone(619) 543-6222

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Rana Ramzi McKay is affiliated with 2 sites of care and 1 medical group

Dr. McKay's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. McKay is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

See all 3 affiliations for Dr. McKay

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Rana Ramzi McKay's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McKay practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
UCSD Hillcrest Medical CenterAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. McKay practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Rana Ramzi McKay is one of 1,502 hematologists and oncologists in California

Hematology and oncology is Dr. McKay's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. McKay is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. McKay's licenses on file in 2 states: California and Massachusetts.

Specialties and state licenses

  • Hematology and oncology, CaliforniaPrimaryLicense A145444 · 2016 to 2026 · taxonomy 207RH0003X
  • Internal medicine, MassachusettsLicense 246591 · 2011 to 2018 · taxonomy 207R00000X

Clinical focus

Dmand AI lists breast cancer, chronic anemia, lymphoma and prostate cancer among the conditions Dr. McKay treats.

Hematologists and oncologists near Dr. McKay

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Rana Ramzi McKay billed Medicare for 637 services in 2024

CMS data shows 637 Medicare services from Dr. McKay across 4 procedure codes in 2024, for 225 Medicare patients. Medicare paid $61,639 for them.

Medicare services, 2024637
Medicare patients225
Paid by Medicare$61,639
Procedure codes4

Dr. McKay's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 7622024: 63716%

Where Dr. McKay's Medicare services took place, 2024

  • In an office20031%
  • In a facility43769%

Dr. McKay compared with the California median for hematologists and oncologists, 2024

  • Dr. McKay
  • California median
Medicare services
637vs 93232% below
Medicare patients
225vs 225Close to median
Part D claims
202vs 39449% below

Medians across 1,367 hematologists and oncologists in California with Dmand AI profiles that report each measure.

Dr. McKay's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. McKay

Need commercial claims for Dr. McKay?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. McKay and other hematologists and oncologists in California.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Rana Ramzi McKay treated 225 Medicare patients in 2024, average age 74

CMS counts 225 Medicare patients who saw Dr. McKay in 2024. The largest group is 75 to 84, with 104 patients. 75% of them have cancer, and 72% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McKay's median patient age at 73, with 11% women.

Medicare patients, 2024225
Average age74
Average risk score2.30
Also on Medicaid12%

Dr. McKay's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. McKay's Medicare patients by sex, 2024

  • Women146%
  • Men21194%

Chronic conditions among Dr. McKay's Medicare patients, 2024

  1. Cancer75%
  2. High cholesterol72%
  3. High blood pressure70%
  4. Arthritis39%
  5. Chronic kidney disease36%
  6. Ischemic heart disease36%
  7. Diabetes25%
  8. Osteoporosis25%

Share of Medicare patients with each condition. A patient can have several.

Dr. McKay's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 73

Patient panel by sex, all payers

  • Women11%
  • Men88%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Rana Ramzi McKay wrote 359 Medicare Part D claims in 2024

In 2024, Dr. McKay wrote 359 Medicare Part D claims for 92 patients. 65% of them were for generic drugs. CMS names the drug for 202 of them, across 8 drugs with 11 or more claims each, at $735,640 in total drug cost. In 2023, CMS named 329 claims across 15 drugs.

Part D claims, 2024359
Drugs named by CMS8
Total drug cost$735,640
Part D patients92

Dr. McKay's Part D claims by kind of drug, 2024

  • Generic235 claims65%
  • Brand-name124 claims35%

Dr. McKay's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. McKay's Part D claims, 2024

  • Opioids6%20 of 359 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 3292024: 20239%

Drugs named by CMS: 8 in 2024, 15 in 2023.

See all prescribing by Dr. McKay

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Rana Ramzi McKay scored 91 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. McKay for performance year 2024, reported as part of a group. Dr. McKay accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McKay as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. McKay's MIPS scores, performance year 2024

  • 91of 100Final score
  • 84.1of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 74of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. McKay by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Rana Ramzi McKay has 263 publications on record

Dmand AI links 263 papers to Dr. McKay, published from 2013 to 2025. 2024 was the busiest year, with 33. The most frequent topics are Carcinoma, Renal Cell, Kidney Neoplasms and Prostatic Neoplasms. Dr. McKay has published most often in Clin Genitourin Cancer. Dr. McKay's most frequent co-authors are Toni K. Choueiri, MD, Brent Shane Rose, MD and Mehmet Asim Bilen, MD.

Papers263
Years published2013 to 2025

Dr. McKay's papers by year, 2016 to 2025

Topics Dr. McKay writes about most

  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Prostatic Neoplasms
  • Prostatic Neoplasms, Castration-Resistant
  • Androgen Antagonists
  • Antineoplastic Combined Chemotherapy Protocols
  • Antineoplastic Agents
  • Immune Checkpoint Inhibitors

Dr. McKay's most frequent co-authors

Recent publications by Dr. McKay

See all 263 publications and co-authors

See who Dr. McKay researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. McKay works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Rana Ramzi McKay has worked on 10 clinical trials

Dmand AI links Dr. McKay to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Prostatic Neoplasms, Prostatic Diseases and Carcinoma, Renal Cell. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. McKay that name 1 trial.

Clinical trials with Dr. McKay by phase

  1. NonePhase 1: no trials
  2. 2Phase 1/2: 2 trials
  3. 4Phase 2: 4 trials
  4. NonePhase 3: no trials
  5. NonePhase 4: no trials

Conditions in Dr. McKay's trials

  • Prostatic Neoplasms
  • Prostatic Diseases
  • Carcinoma, Renal Cell
  • Neoplasm Metastasis
  • Kidney Neoplasms

Investigators on the most trials with Dr. McKay

Recent clinical trials with Dr. McKay

See all 10 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Rana Ramzi McKay received $551,737 in industry payments from 2016 to 2025

CMS Open Payments shows 412 general payments to Dr. McKay from 28 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 68% of the total. Merck Sharp & Dohme Corporation paid the most, $121,625. It also lists 18 research payments totaling $18,041 from 2022 to 2025, naming 1 clinical trial.

General payments to Dr. McKay by program year, 2016 to 2025

General payments to Dr. McKay by kind, 2016 to 2025

$551.7Kin total
  • Consulting fees$376,21968%
  • Speaker and faculty fees$105,62619%
  • Honoraria$32,2306%
  • Travel and lodging$29,4195%
  • Other$8,2431%

Companies that paid Dr. McKay the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. McKay

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Rana Ramzi McKay graduated from University Of Florida College Of Medicine

Dr. McKay graduated from University Of Florida College Of Medicine in 2008. Dr. McKay is a member of ASCO.

  1. Medical schoolUniversity Of Florida College Of Medicine
  2. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Rana Ramzi McKay accepts plans from 16 insurance carriers

Dr. McKay is in network with 16 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.

Plan types Dr. McKay accepts, by number of carriers

  1. PPO10
  2. HMO8
  3. Medicare8
  4. EPO3
  5. POS2
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Rana Ramzi McKay's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Rana Ramzi McKay

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Rana Ramzi McKay's NPI number?

Dr. Rana Ramzi McKay's NPI number is 1306013610. It was assigned on May 15, 2008, and it is active in the NPI Registry.

What kind of doctor is Dr. Rana Ramzi McKay?

Dr. Rana Ramzi McKay is a hematologist and oncologist in San Diego, California. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Rana Ramzi McKay practice?

Dr. McKay practices at 200 W Arbor Dr, San Diego, CA 92103. Dr. McKay's primary practice is UCSD Hillcrest Medical Center in San Diego, California.

What is Dr. Rana Ramzi McKay's office phone number?

The practice phone on file for Dr. McKay is (619) 543-6222.

What is Dr. Rana Ramzi McKay's medical license number?

Dr. McKay holds California license A145444, one of the licenses on file in 2 states.

Which states has Dr. Rana Ramzi McKay been licensed in?

Dmand AI has state licenses on file for Dr. McKay in California (2016 to 2026) and Massachusetts (2011 to 2018).

Which hospitals is Dr. Rana Ramzi McKay affiliated with?

Dr. McKay is affiliated with Hillcrest Medical Center.

What medical group is Dr. Rana Ramzi McKay part of?

Dr. McKay is linked to UC San Diego Health.

Does Dr. Rana Ramzi McKay accept Medicare?

Yes. CMS data shows Dr. McKay billed Medicare for 637 services in 2024, and Dr. McKay accepts Medicare assignment.

Does Dr. Rana Ramzi McKay offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. McKay as offering telehealth services.

Show 11 more questionsShow fewer questions

What is Dr. Rana Ramzi McKay's MIPS score?

Dr. McKay's MIPS final score for performance year 2024 is 91 out of 100, reported as part of a group.

How many Medicare patients does Dr. Rana Ramzi McKay see?

CMS counts 225 Medicare patients who saw Dr. McKay in 2024, with an average age of 74.

Is Dr. Rana Ramzi McKay board certified?

Yes. Dr. McKay is board certified in medical oncology by the American Board of Internal Medicine.

What services does Dr. Rana Ramzi McKay bill to Medicare?

In 2024, Dr. McKay's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99215) and care management and other visits (99497).

Where did Dr. Rana Ramzi McKay go to medical school?

Dr. McKay graduated from University Of Florida College Of Medicine in 2008.

What drugs does Dr. Rana Ramzi McKay prescribe most?

In 2024 Medicare Part D data, Dr. McKay's most prescribed drugs by claims were Prednisone, Abiraterone Acetate and Orgovyx.

Has Dr. Rana Ramzi McKay received payments from drug or device companies?

CMS Open Payments shows $551,737 in general payments to Dr. McKay from 28 companies from 2016 to 2025. The largest total came from Merck Sharp & Dohme Corporation.

How long has Dr. Rana Ramzi McKay been practicing?

Dr. McKay graduated from medical school in 2008, 18 years ago.

Does Dr. Rana Ramzi McKay do research?

Dmand AI links 263 publications to Dr. McKay, published from 2013 to 2025. Dr. McKay has worked on 10 clinical trials.

Who does Dr. Rana Ramzi McKay publish with?

Dr. McKay's most frequent co-authors are Toni K. Choueiri, MD (79 shared papers), Brent Shane Rose, MD (41 shared papers) and Mehmet Asim Bilen, MD (25 shared papers).

What insurance does Dr. Rana Ramzi McKay accept?

Dr. McKay is in network with 16 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in California by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)